Research
9.19.2022

ESMO 2022: BiomeOne: Multi-centric validation of a novel microbiome-based biomarker to predict response to cancer immunotherapy

ready to TALK MICROBIOME?
Reach out to our team with any questions about BiomeDx. We're here to support your understanding of our platform and services.
Arrow right icon
z
z
z
z
i
i
z
z
Let’s build the future of
preventive health.
Bring AI-powered microbiome insights to your customers.
Join our global network of laboratories, clinics, and research centres.